How do you feel about Elon Musk's alliance with Donald Trump? Take our poll.

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

3.1100

+0.0400

(+1.30%)

At close: 04:00PM EDT

3.1100

0.00

(0.00%)

After hours:

04:02PM EDT

Trade prices are not sourced from all markets

All

GlobeNewswire
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in SeptemberPotentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic ADFDA Fast Track designation granted in July for ACI-35.030 (now “JNJ-2056”) for AD Lausanne, Switzerland, September 17, 2024 – AC Immune SA (NASDAQ
Medical Device Network
FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic
Life Molecular Imaging’s PI-2620 tracer compound has received FDA fast track designation across three neurodegenerative conditions.